(Q37468874)

20 August 2017

1 reference

title

Serotonin and Parkinson's disease: On movement, mood, and madness (English)

1 reference

20 August 2017

0 references

1 reference

1

Susan H Fox

1 reference

20 August 2017

3

Jonathan M Brotchie

1 reference

20 August 2017

2

Rosalind Chuang

1 reference

PubMed ID

19412960

20 August 2017

language of work or name

English

0 references

publication date

1 July 2009

1 reference

20 August 2017

1 reference

20 August 2017

24

1 reference

20 August 2017

9

1 reference

20 August 2017

1255-1266

1 reference

Noradrenaline and 5-hydroxytryptamine modulation of brain dopamine function: implications for the treatment of Parkinson's disease

20 August 2017

1 reference

Movement Disorders Associated With the Serotonin Selective Reuptake Inhibitors

21 January 2018

1 reference

Practice parameter: initiation of treatment for Parkinson's disease: an evidence-based review: report of the Quality Standards Subcommittee of the American Academy of Neurology

21 January 2018

1 reference

Tremor in Parkinson's disease and serotonergic dysfunction: an 11C-WAY 100635 PET study

21 January 2018

1 reference

Clozapine in Parkinson's disease tremor. Effects of acute and chronic administration.

21 January 2018

1 reference

Serotonin 5-HT1A agonist improves motor complications in rodent and primate parkinsonian models

21 January 2018

1 reference

Mirtazapine treats resting tremor, essential tremor, and levodopa-induced dyskinesias

21 January 2018

1 reference

D1 receptor blockade improves L-dopa-induced dyskinesia but worsens parkinsonism in MPTP monkeys

21 January 2018

1 reference

Clozapine improves dyskinesias in Parkinson disease: a double-blind, placebo-controlled study

21 January 2018

1 reference

Increased risk of Parkinson's disease after depression: a retrospective cohort study

21 January 2018

1 reference

Clinical and biochemical features of depression in Parkinson's disease

21 January 2018

1 reference

21 January 2018

The serotonin syndrome

1 reference

21 January 2018

1 reference

Serotonin syndrome and the combined use of deprenyl and an antidepressant in Parkinson's disease. Parkinson Study Group.

21 January 2018

1 reference

Serotonin uptake sites and serotonin receptors are altered in the limbic system of schizophrenics.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/MDS.22473

1 reference

20 August 2017

1 reference

PubMed ID

19412960